المؤلفون: Corallo S., Fuca G., Morano F., Salati M., Spallanzani A., Gloghini A., Volpi C. C., Trupia D. V., Lobefaro R., Guarini V., Milione M., Cattaneo L., Antista M., Prisciandaro M., Raimondi A., Sposito C., Mazzaferro V., de Braud F., Pietrantonio F., Di Bartolomeo M.

المساهمون: S. Corallo, G. Fuca, F. Morano, M. Salati, A. Spallanzani, A. Gloghini, C.C. Volpi, D.V. Trupia, R. Lobefaro, V. Guarini, M. Milione, L. Cattaneo, M. Antista, M. Prisciandaro, A. Raimondi, C. Sposito, V. Mazzaferro, F. de Braud, F. Pietrantonio, M. Di Bartolomeo

مصطلحات موضوعية: Epstein-Barr virus infection, Gastric cancer, Molecular classification, Settore MED/18 - Chirurgia Generale, Settore MED/06 - Oncologia Medica

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32272500; info:eu-repo/semantics/altIdentifier/wos/WOS:000529632200001; volume:25; firstpage:1; lastpage:7; numberofpages:7; journal:THE ONCOLOGIST; http://hdl.handle.net/2434/760588Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85084226129

الإتاحة: https://doi.org/10.1634/theoncologist.2020-0037Test
http://hdl.handle.net/2434/760588Test

المؤلفون: Salati M., Filippi R., Vivaldi C., Caputo F., Leone F., Salani F., Cerma K., Aglietta M., Fornaro L., Sperti E., Di Maio M., Ortega C., Fenocchio E., Lombardi P., Cagnazzo C., Depetris I., Gelsomino F., Spallanzani A., Santini D., Silvestris N., Aprile G., Roviello G., Scartozzi M., Cascinu S., Casadei-Gardini A.

المساهمون: Salati, M., Filippi, R., Vivaldi, C., Caputo, F., Leone, F., Salani, F., Cerma, K., Aglietta, M., Fornaro, L., Sperti, E., Di Maio, M., Ortega, C., Fenocchio, E., Lombardi, P., Cagnazzo, C., Depetris, I., Gelsomino, F., Spallanzani, A., Santini, D., Silvestris, N., Aprile, G., Roviello, G., Scartozzi, M., Cascinu, S., Casadei-Gardini, A.

مصطلحات موضوعية: Biliary tract cancer, chemotherapy, cholangiocarcinoma, gallbladder cancer, prognosis, prognostic nutritional index, response prediction, survival

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31773848; info:eu-repo/semantics/altIdentifier/wos/WOS:000502065100001; volume:40; issue:3; firstpage:704; lastpage:711; numberofpages:8; journal:LIVER INTERNATIONAL; http://hdl.handle.net/11570/3233978Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85076390112

الإتاحة: https://doi.org/10.1111/liv.14314Test
http://hdl.handle.net/11570/3233978Test

المؤلفون: VALCAVI, U., INNOCENTI, S., SALATI, M.

المصدر: Chemischer Informationsdienst ; volume 7, issue 7 ; ISSN 0009-2975 2199-2924

الإتاحة: https://doi.org/10.1002/chin.197607213Test

المؤلفون: VALCAVI, U., SALATI, M.

المصدر: Chemischer Informationsdienst ; volume 6, issue 12 ; ISSN 0009-2975 2199-2924

الإتاحة: https://doi.org/10.1002/chin.197512400Test

المؤلفون: Francesco Caputo, Piera Federico, Ingrid Garajová, Matteo Renzulli, Bruno Daniele, Massimo Iavarone, Alessandro Granito, Fabio Gelsomino, Stefania De Lorenzo, Matilde Coriano, Francesco Tovoli, Fabio Piscaglia, Massimiliano Salati

المساهمون: Tovoli F., Garajova I., Gelsomino F., Iavarone M., Federico P., Salati M., Coriano M., Caputo F., De Lorenzo S., Granito A., Renzulli M., Daniele B., Piscaglia F.

المصدر: Liver International. 42:458-467

مصطلحات موضوعية: medicine.medical_specialty, Gastroenterology, liver cancer, FOLFOX, biliary tract cancer, Internal medicine, medicine, Humans, Intrahepatic Cholangiocarcinoma, Retrospective Studies, Hepatology, Performance status, business.industry, Liver Neoplasms, Hazard ratio, medicine.disease, Gemcitabine, Discontinuation, Bile Ducts, Intrahepatic, Bile Duct Neoplasms, Hepatocellular carcinoma, outcome, prognosis, cholangiocarcinoma, Liver cancer, business, medicine.drug

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9290b947ce8df25ff01b0043f1ee574dTest
https://doi.org/10.1111/liv.15117Test